Patents by Inventor Gregor Larbig
Gregor Larbig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11959007Abstract: The present invention relates to a novel class of polymers which can be used as dielectric material for the preparation of passivation layers in electronic devices. The polymers are prepared from polymerizable compounds having mesogenic groups and they provide excellent film forming capability and excellent mechanical properties and have a low dielectric constant and a low coefficient of thermal expansion (CTE). There is further provided a method for forming said polymers and an electronic device containing said polymers as dielectric material. Beyond that, the present invention relates to a manufacturing method for preparing a packaged microelectronic structure and to a microelectronic device comprising said packaged microelectronic structure formed by said manufacturing method.Type: GrantFiled: January 21, 2019Date of Patent: April 16, 2024Assignee: MERCK PATENT GMBHInventors: Frank Meyer, Gregor Larbig, Karsten Koppe
-
Publication number: 20240010796Abstract: The present invention relates to a new class of dielectric polymer material, which is particularly suitable for the manufacturing of electronic devices. The dielectric polymer material is formed by reacting bismaleimide compounds and shows an advantageous well-balanced profile of favorable material properties. The bismaleimide compounds have an oligomeric structure with a cardo and/or spiro moiety containing repeating unit in the middle part of the molecule and maleimide groups at each terminal end of the molecule. There is further provided a method for forming said dielectric polymer material and an electronic device comprising the same as dielectric material.Type: ApplicationFiled: December 2, 2021Publication date: January 11, 2024Applicant: MERCK PATENT GMBHInventors: Gregor LARBIG, Frank Egon MEYER, Pawel MISKIEWICZ
-
Patent number: 11834598Abstract: The present invention relates to a polymerizable mixture which can be used to form a dielectric material for the preparation of passivation layers in electronic devices. The polymerizable mixture comprises a first monomer and a second monomer which may react to form a copolymer providing excellent film forming capability, excellent thermal properties and excellent mechanical properties. There is further provided a method for forming said copolymers and an electronic device containing said copolymers as dielectric material. Beyond that, the present invention relates to a manufacturing method for preparing a packaged microelectronic structure and to a microelectronic device comprising said packaged microelectronic structure formed by said manufacturing method.Type: GrantFiled: October 15, 2019Date of Patent: December 5, 2023Assignee: Merck Patent GmbHInventors: Gregor Larbig, Pawel Miskiewicz, Frank Meyer, Joerg Pahnke, Karsten Koppe
-
Publication number: 20210355381Abstract: The present invention relates to a polymerizable mixture which can be used to form a dielectric material for the preparation of passivation layers in electronic devices. The polymerizable mixture comprises a first monomer and a second monomer which may react to form a copolymer providing excellent film forming capability, excellent thermal properties and excellent mechanical properties. There is further provided a method for forming said copolymers and an electronic device containing said copolymers as dielectric material. Beyond that, the present invention relates to a manufacturing method for preparing a packaged microelectronic structure and to a microelectronic device comprising said packaged microelectronic structure formed by said manufacturing method.Type: ApplicationFiled: October 15, 2019Publication date: November 18, 2021Applicant: Merck Patent GmbHInventors: Gregor LARBIG, Pawel MISKIEWICZ, Frank MEYER, Joerg PAHNKE, Karsten KOPPE
-
Publication number: 20210355383Abstract: The present invention relates to a polymerizable mixture which can be used to form a dielectric material for the preparation of passivation layers in electronic devices. The polymerizable mixture comprises a first monomer and a second monomer which may react to form a copolymer providing excellent film forming capability, excellent thermal properties and excellent mechanical properties. There is further provided a method for forming said copolymers and an electronic device containing said copolymers as dielectric material. Beyond that, the present invention relates to a manufacturing method for preparing a packaged microelectronic structure and to a microelectronic device comprising said packaged microelectronic structure formed by said manufacturing method.Type: ApplicationFiled: October 15, 2019Publication date: November 18, 2021Applicant: MERCK PATENT GMBHInventors: Gregor LARBIG, Pawel MISKIEWICZ
-
Publication number: 20210062091Abstract: The present invention relates to a novel class of polymers which can be used as dielectric material for the preparation of passivation layers in electronic devices. The polymers are prepared from polymerizable compounds having mesogenic groups and they provide excellent film forming capability and excellent mechanical properties and have a low dielectric constant and a low coefficient of thermal expansion (CTE). There is further provided a method for forming said polymers and an electronic device containing said polymers as dielectric material. Beyond that, the present invention relates to a manufacturing method for preparing a packaged microelectronic structure and to a microelectronic device comprising said packaged microelectronic structure formed by said manufacturing method.Type: ApplicationFiled: January 21, 2019Publication date: March 4, 2021Applicant: MERCK PATENT GMBHInventors: Frank MEYER, Gregor LARBIG, Karsten KOPPE
-
Patent number: 10413614Abstract: The present invention relates to a conjugate containing at least one kidney-selective carrier molecule and at least one active compound which has a protective action for the kidney against nephrotoxic active compounds, to a process for the preparation of the conjugate, to the use thereof for the protection of the kidney against nephrotoxic active compounds, and to a medicament comprising the conjugate.Type: GrantFiled: October 3, 2017Date of Patent: September 17, 2019Assignee: Merck Patent GmbHInventors: Armin Kuebelbeck, Gregor Larbig, Stefan Arnold, Walter Mier, Uwe Haberkorn
-
Patent number: 10111952Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunisation of a mammal.Type: GrantFiled: October 6, 2017Date of Patent: October 30, 2018Assignee: MERCK PATENT GmbHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
-
Patent number: 10065993Abstract: The present invention relates to a peptide which consists of more than 50% of sequence sections of the formula -(An-Bm-Co)-, and to a conjugate containing the peptide and at least one covalently bonded active compound, and to a process for the preparation of the conjugate. The present invention furthermore relates to the use of the peptide and the conjugate for targeting of the kidney, and to a medicament comprising the peptide or conjugate.Type: GrantFiled: April 16, 2014Date of Patent: September 4, 2018Assignee: MERCK PATENT GMBHInventors: Armin Kuebelbeck, Gregor Larbig, Stefan Arnold, Walter Mier
-
Publication number: 20180071386Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunisation of a mammal.Type: ApplicationFiled: October 6, 2017Publication date: March 15, 2018Applicant: Merck Patent GmbHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
-
Publication number: 20180015173Abstract: The present invention relates to a conjugate containing at least one kidney-selective carrier molecule and at least one active compound which has a protective action for the kidney against nephrotoxic active compounds, to a process for the preparation of the conjugate, to the use thereof for the protection of the kidney against nephrotoxic active compounds, and to a medicament comprising the conjugate.Type: ApplicationFiled: October 3, 2017Publication date: January 18, 2018Applicant: Merck Patent GmbHInventors: Armin KUEBELBECK, Gregor LARBIG, Stefan ARNOLD, Walter MIER, Uwe HABERKORN
-
Patent number: 9808535Abstract: The present invention relates to a conjugate containing at least one kidney-selective carrier molecule and at least one active compound which has a protective action for the kidney against nephrotoxic active compounds, to a process for the preparation of the conjugate, to the use thereof for the protection of the kidney against nephrotoxic active compounds, and to a medicament comprising the conjugate.Type: GrantFiled: April 16, 2014Date of Patent: November 7, 2017Assignee: MERCK PATENT GMBHInventors: Armin Kuebelbeck, Gregor Larbig, Stefan Arnold, Walter Mier, Uwe Haberkorn
-
Patent number: 9808521Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunization of a mammal.Type: GrantFiled: June 30, 2016Date of Patent: November 7, 2017Assignee: MERCK PATENT GMBHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
-
Publication number: 20160303228Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunisation of a mammal.Type: ApplicationFiled: June 30, 2016Publication date: October 20, 2016Applicant: Merck Patent GmbHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
-
Patent number: 9433673Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunization of a mammal.Type: GrantFiled: February 2, 2015Date of Patent: September 6, 2016Assignee: MERCK PATENT GMBHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
-
Publication number: 20160199505Abstract: The present invention relates to a peptide which consists of more than 50% of sequence sections of the formula -(An-Bm-Co)-, and to a conjugate containing the peptide and at least one covalently bonded active compound, and to a process for the preparation of the conjugate. The present invention furthermore relates to the use of the peptide and the conjugate for targeting of the kidney, and to a medicament comprising the peptide or conjugate.Type: ApplicationFiled: April 16, 2014Publication date: July 14, 2016Applicant: MERCK PATENT GMBHInventors: Armin KUEBELBECK, Gregor LARBIG, Stefan ARNOLD, Walter MIER
-
Publication number: 20160114054Abstract: The present invention relates to a conjugate containing at least one kidney-selective carrier molecule and at least one active compound which has a protective action for the kidney against nephrotoxic active compounds, to a process for the preparation of the conjugate, to the use thereof for the protection of the kidney against nephrotoxic active compounds, and to a medicament comprising the conjugate.Type: ApplicationFiled: April 16, 2014Publication date: April 28, 2016Applicant: Merck Patent GmbHInventors: Armin KUEBELBECK, Gregor LARBIG, Stefan ARNOLD, Walter MIER, Uwe HABERKORN
-
Publication number: 20150224189Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunisation of a mammal.Type: ApplicationFiled: February 2, 2015Publication date: August 13, 2015Applicant: MERCK PATENT GMBHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig
-
Patent number: 9078929Abstract: The present invention relates to ?-polylysine conjugates, in particular conjugates of ?-polylysine with compounds carrying carboxyl groups, and to the preparation and use thereof for targeting of the kidney.Type: GrantFiled: July 9, 2010Date of Patent: July 14, 2015Assignee: Merck Patent GmbHInventors: Armin Kuebelbeck, Gregor Larbig, Walter Mier, Barbro Beijer, Uwe Haberkorn
-
Patent number: 8980324Abstract: The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The nanoparticles can be used for the immunoprophylaxis or immunotherapy of cancer. The invention also relates to a method for the targeting of antigens at antigen-presenting cells and for the activation of the immune system, where the efficiency of targeting and/or immunoactivation are set via the particle characteristics. The invention also relates to a method for the active and passive immunization of a mammal.Type: GrantFiled: July 13, 2009Date of Patent: March 17, 2015Assignee: Merck Patent GmbHInventors: Markus Weigandt, Andrea Hanefeld, Armin Kuebelbeck, Gregor Larbig